Kaiser Permanente scientists and clinicians are running clinical trials and tracking trends in patient care.
Scientists throughout Kaiser Permanente are working with clinicians and institutions across the country to improve understanding of COVID-19 and develop tools to prevent and treat the disease.
Research scientists from Kaiser Permanente’s Division of Research in Northern California, Center for Health Research in the Northwest, and Department of Research & Evaluation in Southern California are participating in phase 3 trials of a vaccine developed by Pfizer and BioNTech.
In addition, scientists at Kaiser Permanente Health Research Institute in Seattle are now enrolling participants in phase 3 trials of the National Institute of Allergy and Infectious Diseases/Moderna Inc. co-developed vaccine.
Lisa A Jackson, MD, MPH, a senior investigator at the Kaiser Permanente Health Research Institute, led phase 1 of this first-in-human clinical trial, which was developed and produced in record time.
“The world urgently needs vaccines to protect against COVID-19,” Dr. Jackson said. “We are glad to be able to contribute to these efforts.”
The NIAID-Moderna Inc. and the Pfizer/BioNTech vaccines are among 5 vaccines selected by National Institutes of Health for high priority development.
Scientists at Kaiser Permanente are also participating in other clinical trials to evaluate the safety and effectiveness of drug treatments for COVID-19.
Kaiser Permanente hospitals were among the world’s largest enrollers of patients into remdesivir clinical trials. Trials took place in 152 medical facilities worldwide, including 17 Kaiser Permanente hospitals — 15 in California and 2 in the Northwest.
“We were able to mobilize and quickly set up a multisite clinical trial — something that normally takes months — in a matter of days,” said William Towner, MD, principal investigator for the remdesivir clinical trials at Kaiser Permanente in Southern California.
Current data show that remdesivir shortens the time to recovery for people hospitalized with COVID-19. “An NIH-sponsored trial is now being conducted by Kaiser Permanente to examine if adding an immunosuppressive agent to remdesivir can provide additional benefit for patients,” said Richard Mularski, MD, who leads the trial at the Kaiser Permanente Center for Health Research in the Northwest.
Several Kaiser Permanente regions are participating in a Mayo Clinic-led observational study in which blood plasma from those who have recovered from COVID-19 is used to treat some patients with severe COVID-19 or those at high risk for progression to severe COVID-19. The theory is that a donor's plasma contains antibodies that may be able to attack the virus to help patients recover more rapidly.
Our scientists and physicians are using Kaiser Permanente’s robust data to better assess and manage risk for patients with suspected or confirmed COVID-19. One study is assessing the risks associated with taking antihypertensive medications in patients with confirmed COVID-19 infection and high blood pressure.
Researchers are also studying how the pandemic may affect trends in care for conditions other than COVID-19. For example, despite the availability of immediate emergency care, research by Kaiser Permanente showed that the weekly number of patients admitted to Kaiser Permanente hospitals in Northern California for heart attacks after the onset of the COVID-19 pandemic fell to nearly half of what would be expected. The findings were reported in a research letter published in the New England Journal of Medicine.
Kaiser Permanente’s extensive research capabilities are helping to identify solutions to the COVID-19 pandemic. Our structure as an integrated health system means we have a direct pathway to incorporate our research findings into the clinical care our members receive. Learn more about research at Kaiser Permanente.
Six steps help you prep for winter trips.
Nearsightedness, also known as myopia, is on the rise. To reverse that …
The updated vaccine is recommended for everyone 6 months and older.
Stories in the Department of Research & Evaluation 2022 Annual Report demonstr …
A new location-based vaccine strategy by Kaiser Permanente was successful …
Kaiser Permanente researchers led analysis of large, diverse group of young …
Vaccinations, testing, and treatment are still widely accessible. Member …
Testing is the most important way you can help control the spread of COVID-19.
With the COVID-19 public health emergency ending, states, community organizati …
Kaiser Permanente offers many high-quality, convenient options to help …
Learning from this historic health crisis will better prepare us for future …
A Kaiser Permanente study finds COVID-19 patients treated quickly with …
From avid snowboarder to chronically ill patient. How Kaiser Permanente …
Almost 16 million people in the United States have chronic obstructive …
New research shows blood pressure patterns early in pregnancy can identify …
Two leading infectious disease physicians discuss what to expect with COVID-19 …
Kaiser Permanente study shows that exercise is associated with lower rates …
Con tanto que se habla de una “tridemia” de enfermedades respiratorias, …
Kaiser Permanente research finds that patient intervention is linked to …
As colder weather and rain arrive in Oregon, Katie Sharff, MD, an infectious …
Kaiser Permanente Center for Thoracic Aortic Disease study confirms low …
New care option offers pregnant patients a mix of in-person and video visits.
We reflect on 3 major COVID-19 surges, urgent vaccination efforts, and …
A Kaiser Permanente study of more than 250,000 people shows that patients …
How to give your baby the health benefits of breast milk during a pandemic.
Kaiser Permanente study finds vaccinated surgical patients had no elevated …
Providing safe and effective vaccinations to children is an important step …
Kaiser Permanente study suggests that for patients with severe asymptomatic …
Kaiser Permanente study finds culturally tailored program leads to long-term …
Kaiser Permanente research ties breast arterial calcification to increased …
California produces nearly half of the nation's fruits and vegetables, …
Kaiser Permanente finds the Pfizer COVID-19 third dose vaccine protection …
We donated over $28 million worth of face masks, hand sanitizer, and other …
Two years into the COVID-19 pandemic, a Kaiser Permanente pediatrician …
Kaiser Permanente study assessed Pfizer COVID-19 vaccine effectiveness …
As unhealthy eating behaviors increased during the pandemic, care teams …
Kaiser Permanente grants are supporting businesses such as the Carefree …
Grants expand support for faith-based organizations working to protect …
After serving on the White House COVID-19 response team, Bechara Choucair, …
Kaiser Permanente convened a panel to discuss vaccinations and our return …
Here are some tips to keep you and your little superheroes safe.
An Oregon team of scientists is broadening our knowledge of COVID-19 vaccine …
Kaiser Permanente and other leading companies are mandating COVID-19 shots …
A statement from Kaiser Permanente chair and chief executive officer Greg …
Kaiser Permanente study supports eventual use of new way to estimate kidney …
A statement from Kaiser Permanente chair and chief executive officer Greg …
Kaiser Permanente’s partnership with Local Initiatives Support Corporation, …
For people without a safe place to call home, good health is often out …
Commitment to high-quality, affordable, compassionate care remains in a …
Video visits and virtual collaboration speed cancer care transformation …
Kaiser Permanente study finds that the decrease reported during the onset …
Kaiser Permanente research underscores the importance of culturally appropriat …
The final in a series capturing the reflections of Kaiser Permanente employees …
A multipart series capturing the reflections of Kaiser Permanente employees …
As vaccines bring hope to end the pandemic, Kaiser Permanente’s toolkit …
A statement from CEO Greg A. Adams about the American Rescue Plan Act.
Available 24/7 with no appointment, e-visits offer Kaiser Permanente members …
A diabetes specialist talks about new trends in providing care, and innovation …
Health care system provides model for screening patients for access to …
With expanded telehealth options, Kaiser Permanente members get convenient …
Skilled care and thorough infection-prevention protocols kept Eleanor Gorman …
Kaiser Permanente pledges more than $28 million in grants, many to address …
Newsweek’s Best Maternity Care Hospitals 2020 report recognizes Kaiser …
Kaiser Permanente is part of a phase 1 trial testing a vaccine designed …
Kaiser Permanente’s fully integrated telehealth capabilities place quality …
Helping people strengthen connections, maintain healthy routines, and find …
New Kaiser Permanente research backs anecdotal reports that people are …
Kaiser Permanente nurses have been saving lives on the front lines since …
Over 50 years of early Kaiser Permanente electronic health records since …
Kaiser Permanente's Division of Research has conducted pioneering health …